118 results
8-K
EX-2.2
ORTX
Orchard Therapeutics plc
24 Jan 24
Termination of a Material Definitive Agreement
4:17pm
under the Prospectus Regulation (EU) 2017/1129 (including as it has been retained in the United Kingdom by virtue of the European Union (Withdrawal
DEFM14A
ORTX
Orchard Therapeutics plc
16 Nov 23
Proxy related to merger
4:45pm
was approved in the European Union, the United Kingdom, Iceland, Liechtenstein and Norway under the brand name Libmeldy for eligible patients with early … or recognize or certify any labor union, labor organization, works council, or group of employees as the bargaining representative for any employees of Orchard
8-K
EX-99.1
ORTX
Orchard Therapeutics plc
13 Nov 23
Orchard Therapeutics Reports Third Quarter 2023 Financial Results and Highlights Recent Business Accomplishments
7:05am
of Product Characteristics (SmPC) available on the European Medicines Agency (EMA) website.
Libmeldy is approved in the European Union, UK, Iceland
PREM14A
ORTX
Orchard Therapeutics plc
3 Nov 23
Preliminary proxy related to merger
5:11pm
is OTL-200, which was approved in the European Union, the United Kingdom, Iceland, Liechtenstein and Norway under the brand name Libmeldy for eligible … agreement or recognize or certify any labor union, labor organization, works council, or group of employees as the bargaining representative for any
DEFA14A
kjj lfkm52b
17 Oct 23
Additional proxy soliciting materials
4:32pm
DEFA14C
xsajbq3jvi 6fgw6mfl
5 Oct 23
Additional information
4:48pm
DEFA14C
1quq647u n6
5 Oct 23
Additional information
4:45pm
DEFA14C
56ohz2jh7 ap6brzhd
5 Oct 23
Additional information
4:40pm
DEFA14A
4h9il
5 Oct 23
Additional proxy soliciting materials
9:07am
8-K
EX-2.1
srvtr9j jl
5 Oct 23
Kyowa Kirin to Acquire Orchard Therapeutics
9:05am
8-K
EX-99.1
m05qcax3e34ot0e5i
5 Oct 23
Kyowa Kirin to Acquire Orchard Therapeutics
9:05am
8-K
EX-99.1
2mhaqlblefo28d9
18 Sep 23
Orchard Therapeutics Announces Acceptance of Biologics License Application for OTL-200 in MLD and Receives Priority Review
7:07am
424B3
lio0 a207
21 Aug 23
Prospectus supplement
4:32pm
S-8
EX-5.1
ubkkpi lxht9ghlkib
10 Aug 23
Registration of securities for employees
5:04pm
8-K
EX-99.1
w0aae2
3 Aug 23
Orchard Therapeutics Completes Submission of Biologics License Application for OTL-200 in MLD to U.S. FDA
7:05am
8-K
EX-99.3
htvh bzsrj8
23 May 23
Regulation FD Disclosure
7:06am